Purpose(Empty Backbone) C-terminal fusion to moxCerulean3
|Item||Catalog #||Description||Quantity||Price (USD)|
|Plasmid||68066||Standard format: Plasmid sent in bacteria as agar stab||1||$85|
This material is available to academics and nonprofits only.
Modifications to backboneoxFP inserted via AgeI/NotI restriction sites, removing EGFP
Vector typeMammalian Expression
- Promoter CMV
/ Fusion Protein
- moxCerulean3 (C terminal on backbone)
Growth in Bacteria
Bacterial Resistance(s)Kanamycin, 50 μg/mL
Copy numberHigh Copy
- Cloning method Restriction Enzyme
- 5′ sequencing primer CMV-F (Common Sequencing Primers)
Terms and Licenses
- Not Available to Industry
- Zeocin® is an InvivoGen trademark.
Derived from Cerulean3.
Brightness 36 (product of extinction coefficient and quantum yield and divided by 1,000).
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
For your Materials & Methods section:moxCerulean3 was a gift from Erik Snapp (Addgene plasmid # 68066 ; http://n2t.net/addgene:68066 ; RRID:Addgene_68066)
For your References section:A palette of fluorescent proteins optimized for diverse cellular environments. Costantini LM, Baloban M, Markwardt ML, Rizzo M, Guo F, Verkhusha VV, Snapp EL. Nat Commun. 2015 Jul 9;6:7670. doi: 10.1038/ncomms8670. 10.1038/ncomms8670 PubMed 26158227